Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 4 6Phase 2 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 699Breast Neoplasms 629Neoplasms 582Leukemia, Myeloid, Acute 481Colorectal Neoplasms 455Multiple Myeloma 444Melanoma 424Prostatic Neoplasms 383Neoplasm Metastasis 370Pancreatic Neoplasms 361Recurrence 347Lymphoma 340Ovarian Neoplasms 322Lung Neoplasms 297Lymphoma, Non-Hodgkin 295Leukemia 287Glioblastoma 275Precursor Cell Lymphoblastic Leukemia-Lymphoma 249Stomach Neoplasms 246Leukemia, Lymphocytic, Chronic, B-Cell 235Carcinoma, Hepatocellular 231Squamous Cell Carcinoma of Head and Neck 219Lymphoma, Large B-Cell, Diffuse 217Myelodysplastic Syndromes 212Carcinoma, Renal Cell 210Lymphoma, Follicular 183Head and Neck Neoplasms 172Brain Neoplasms 169Triple Negative Breast Neoplasms 167Lymphoma, Mantle-Cell 167

Interventions

Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Depressive Disorder, Major × Clear all
NCT03833206 2026-04-20

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

BioLite, Inc.

Phase 1/2 Not yet recruiting
12 enrolled

Depressive Disorder, Major

NCT04471818 2023-09-28

KODIAC

Instituto Nacional de Cancerologia de Mexico

Phase 1/2 Completed
19 enrolled

Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon âš¡